Navigation Links
A fresh look at existing therapies: Researchers explore ways to teach approved drugs new tricks
Date:10/24/2007

rugs across populations of patients, and preliminary results are promising, the researchers say. Sorafenib, sunitinib, and temsirolimus were all approved for use in renal cell carcinoma within the last two years.

Neoadjuvant therapy is an old idea, with the primary intent to downstage a tumor and increase the likelihood of successful surgical resection. We are using it to extract biomarker information on efficacy of treatment instead, said W. Kimryn Rathmell, M. D., Ph.D., of the Division of Hematology/Oncology at the Lineberger Comprehensive Cancer Center.

In this study, researchers measured patients tumor responses to a short course of treatment before surgery using CT imaging, and analyzed potential biomarkers using functional imaging with PET imaging, blood and urine analysis before and after treatment, and the regulation of genes and proteins within the tumor.

Their first results, evaluating 4 to 8 weeks of sorafenib in 30 patients prior to surgery is currently under analysis. Early results show that among 10 of the 30 patients, the average response is a 10 percent reduction in size of the primary tumor, with a range between 0.8 percent and 28 percent. No tumor progression has been observed in any of the patients, and no unexpected surgical complications have been observed, Dr. Rathmell says.

Treating advanced renal cell carcinoma is difficult because results from clinical trials of new agents in advanced disease are difficult to interpret due to lack of good biomarkers, Dr. Rathmell says. This is because there is limited access to tumor tissue acquired at or around the time of the treatment, the influence of prior therapy received by patients, and the relative co-morbidities these patients have compared to newly diagnosed patient, she said.

Additionally, no genetically engineered mouse models have been validated for renal cell carcinoma, Dr. Rathmell says. Conventional xenograft studies, growing human tumor cells i
'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Fresh approach to TB treatment
2. Fresh warnings to doctors regarding abortion pill
3. Refreshing Assam Tea Now At The Nearest Post Office
4. Fresh Cases of Bird-Flu Prepares the Ground for More Chicken Martyrs
5. Fresh Bird Flu Cases Spotted In Southern Russia
6. Pakistan Scared By Fresh Bird Flu Case
7. Fresh Polio Cases Reported In Uttar Pradesh
8. Nothing Can Equate Fresh Vegetables and Fruits
9. Fresh Outbreak Of Bird Flu In Nigeria
10. Foreign Fresher Students Offered Scholarship By Fudan
11. Fresh bird flu vaccines made in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... May 29, 2015 Designed with the ... up to create an all new, exclusive line of ... formulated with the latest and greatest, high impact, result ... to be effective. The 24/7 Series can be used ... and even the casual fitness enthusiasts. There are no ...
(Date:5/29/2015)... 29, 2015 Javlin continues to fulfill ... headquarters and a larger team, with the intention to ... market share in the U.S. and Canada. , Javlin ... achieved significant growth in 2014 with its strongest earnings ... data integration platform, CloverETL. To accelerate further progress and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 This ... current state of the Naproxen industry.The report provides ... classifications, applications and industry chain structure. The ... international markets including development trends, competitive landscape analysis, ... are discussed as well as manufacturing processes and ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
... Group Upgrades from Allscripts Document Management; Expects ... Break-Even on Clinical & Financial Investment, CHICAGO ... leading provider of clinical software, connectivity and,information solutions ... The Heart Center Medical Group has selected the ...
... Medicare Fraud Strike Force, WASHINGTON, April 30 ... late yesterday of Medicare fraud,Assistant Attorney General Alice S. ... Acosta of the Southern District of Florida,announced today., ... Caos, 62, guilty on all,charged counts, including: conspiracy to ...
... PARK, Ohio, April 30 "Opportunities for,Next-Generation ... Medical,Devices Conference, will bring together the diverse ... cardiovascular, orthopaedic,neurological and pulmonary applications., Hosted ... world,s leading,materials society, this unique forum will ...
... Idiopathic pulmonary fibrosis (IPF) patients learn from specialists,seek ... The following announcement,was released by The Coalition ... Free Educational Seminar for Patients and Their,Families, ... with The,Coalition for Pulmonary Fibrosis (CPF), is hosting ...
... Pa., April 30 West Pharmaceutical,Services, Inc., (NYSE: ... 2008,Annual Meeting of Shareholders. The meeting will be held ... The live webcast can be accessed through the ... Please allow extra time prior,to the live webcast to ...
... for all holders of a valid press card / formal ... press facilities, including a working room, and the press office ... relevant experts. , You can register for ... direct any queries to the EULAR Press Office on ...
Cached Medicine News:Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:Miami Jury Convicts Dermatologist of Medicare Fraud 2Health News:Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 3Health News:West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast 2
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Companies"  to their offering.  ... interference (RNAi) or gene silencing involves the ... inside the cell, this material is processed ...
(Date:5/28/2015)... May 28, 2015 AlloSource ®, ... cellular, bone, skin and soft-tissue allografts for use ... patient healing, today announced that AlloWrap® DS, its ... to the high-cost reimbursement category. ... and their patients," said Kimberly French , ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... WEBSTER, Texas, Nov. 10, 2011 IDEV Technologies, Incorporated ... for the company,s 6 French (6Fr) SUPERA VERITAS Transhepatic ... for sale outside the U.S. earlier this year, is ... the unique SUPERA stent, currently cleared in the U.S. ...
... Vascular Designs, Inc., a medical device manufacturing company, today ... FDA marketing clearance in 2009 – is now in ... in the treatment of liver cancer. The IsoFlow™ Infusion ... target and isolate areas within the body where the ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Breakthrough Cancer Treatment Now in Use at UC Davis Medical Center 2
Medium....
Goldman single hook....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
Medicine Products: